Navarra reduces the impact of hospital pharmaceutical spending by 20 million with the use of biosimilar medicines in the last three years

Industry news

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE